JP2005530730A5 - - Google Patents

Download PDF

Info

Publication number
JP2005530730A5
JP2005530730A5 JP2003584041A JP2003584041A JP2005530730A5 JP 2005530730 A5 JP2005530730 A5 JP 2005530730A5 JP 2003584041 A JP2003584041 A JP 2003584041A JP 2003584041 A JP2003584041 A JP 2003584041A JP 2005530730 A5 JP2005530730 A5 JP 2005530730A5
Authority
JP
Japan
Prior art keywords
alkyl
alkoxy
independently
amino
fully halogenated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003584041A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005530730A (ja
JP4578106B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/011094 external-priority patent/WO2003087085A1/en
Publication of JP2005530730A publication Critical patent/JP2005530730A/ja
Publication of JP2005530730A5 publication Critical patent/JP2005530730A5/ja
Application granted granted Critical
Publication of JP4578106B2 publication Critical patent/JP4578106B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2003584041A 2002-04-11 2003-04-10 サイトカインインヒビターとしてのヘテロ環式アミド誘導体 Expired - Lifetime JP4578106B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37167102P 2002-04-11 2002-04-11
PCT/US2003/011094 WO2003087085A1 (en) 2002-04-11 2003-04-10 Heterocyclic amide derivatives as cytokine inhibitors

Publications (3)

Publication Number Publication Date
JP2005530730A JP2005530730A (ja) 2005-10-13
JP2005530730A5 true JP2005530730A5 (cg-RX-API-DMAC7.html) 2006-06-08
JP4578106B2 JP4578106B2 (ja) 2010-11-10

Family

ID=29250721

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003584041A Expired - Lifetime JP4578106B2 (ja) 2002-04-11 2003-04-10 サイトカインインヒビターとしてのヘテロ環式アミド誘導体

Country Status (9)

Country Link
US (1) US7550461B2 (cg-RX-API-DMAC7.html)
EP (1) EP1497278B1 (cg-RX-API-DMAC7.html)
JP (1) JP4578106B2 (cg-RX-API-DMAC7.html)
AT (1) ATE469142T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003224923A1 (cg-RX-API-DMAC7.html)
CA (1) CA2478232C (cg-RX-API-DMAC7.html)
DE (1) DE60332717D1 (cg-RX-API-DMAC7.html)
ES (1) ES2343787T3 (cg-RX-API-DMAC7.html)
WO (1) WO2003087085A1 (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003224923A1 (en) * 2002-04-11 2003-10-27 Boehringer Ingelheim Pharmaceuticals, Inc. Heterocyclic amide derivatives as cytokine inhibitors
US7078419B2 (en) * 2003-03-10 2006-07-18 Boehringer Ingelheim Pharmaceuticals, Inc. Cytokine inhibitors
CA2560387C (en) 2004-05-03 2013-09-24 Boehringer Ingelheim Pharmaceuticals, Inc. Cytokine inhibitors
EP1867646A1 (en) * 2004-05-03 2007-12-19 Boehringer Ingelheim Pharmaceuticals, Inc. Cytokine inhibitors
CA2577446C (en) * 2004-08-25 2013-06-25 Boehringer Ingelheim Pharmaceuticals, Inc. 2-arylcarbamoyl-indoles as cytokine inhibitors
US7612200B2 (en) * 2004-12-07 2009-11-03 Locus Pharmaceuticals, Inc. Inhibitors of protein kinases
US7741479B2 (en) * 2004-12-07 2010-06-22 Locus Pharmaceuticals, Inc. Urea inhibitors of MAP kinases
EP1838690A2 (en) * 2004-12-21 2007-10-03 Devgen N.V. Compounds with kv4 ion channel activity
EP1873144B1 (en) 2005-04-20 2014-07-23 Takeda Pharmaceutical Company Limited Fused heterocyclic compound
EP1973408A2 (en) * 2006-01-04 2008-10-01 Locus Pharmaceuticals, Inc. Inhibitors of protein kinases
CA2722923C (en) 2008-04-29 2016-08-02 Boehringer Ingelheim International Gmbh Indazole compounds as ccr1 receptor antagonists
EP2297112B1 (en) 2008-05-06 2013-04-03 Boehringer Ingelheim International GmbH Pyrazole compounds as ccr1 antagonists
EP2161266A1 (en) * 2008-08-22 2010-03-10 EVOTEC Neurosciences GmbH Benzofuran derivatives as orexin receptor antagonists
AP2739A (en) 2008-09-26 2013-09-30 Boehringer Ingelheim Int Azaindazole compounds as CCRI receptor antagonists
PE20121433A1 (es) 2009-10-21 2012-11-10 Boehringer Ingelheim Int Compuestos de indazol y pirazolopiridina como antagonistas del receptor de ccr1
US8927550B2 (en) 2009-10-27 2015-01-06 Boehringer Ingelheim International Gmbh Heterocyclic compounds as CCR1 receptor antagonists
EP2563787B1 (en) 2010-04-30 2014-11-26 Boehringer Ingelheim International GmbH Azaindazole amide compounds as ccr1 receptor antagonists
JP5684406B2 (ja) 2010-12-23 2015-03-11 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｃｒ１受容体アンタゴニストとしてのピラゾロピペリジン化合物
CN117510460A (zh) * 2023-10-30 2024-02-06 贵州大学 一种含磺酰胺单元的苯并[b]噻吩衍生物、其制备方法及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4317076A1 (de) * 1993-05-21 1994-11-24 Bayer Ag Benzthiophencarbonsäureamid-S-oxide
DE19642529A1 (de) * 1996-10-15 1998-04-16 Bayer Ag Aminophenolderivate
US5994398A (en) * 1996-12-11 1999-11-30 Elan Pharmaceuticals, Inc. Arylsulfonamides as phospholipase A2 inhibitors
SK286123B6 (sk) * 1998-05-15 2008-04-07 Astrazeneca Ab Benzamidové deriváty, spôsob ich prípravy, farmaceutická kompozícia a ich použitie na prípravu liečiva na liečenie chorôb sprostredkovaných cytokínmi
HUP0104060A3 (en) * 1998-09-25 2002-04-29 Astrazeneca Ab Benzamide derivatives and their use as cytokine inhibitors, process for their preparation and medicaments containing them
WO2000055139A2 (en) 1999-03-12 2000-09-21 Boehringer Ingelheim Pharmaceuticals, Inc. Heterocyclic urea and related compounds useful as anti-inflammatory agents
TWI290136B (en) * 2000-04-05 2007-11-21 Daiichi Seiyaku Co Ethylenediamine derivatives
AU2001277731A1 (en) * 2000-08-09 2002-02-18 Welfide Corporation Fused bicyclic amide compounds and medicinal use thereof
JP2005507367A (ja) * 2001-04-13 2005-03-17 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド １，４−二置換ベンゾ縮合化合物
AR034897A1 (es) * 2001-08-07 2004-03-24 Hoffmann La Roche Derivados n-monoacilados de o-fenilendiaminas, sus analogos heterociclicos de seis miembros y su uso como agentes farmaceuticos
AU2003224923A1 (en) * 2002-04-11 2003-10-27 Boehringer Ingelheim Pharmaceuticals, Inc. Heterocyclic amide derivatives as cytokine inhibitors

Similar Documents

Publication Publication Date Title
JP2005530730A5 (cg-RX-API-DMAC7.html)
CN1095841C (zh) 化合物
TW403742B (en) Oxazole derivatives for inhibiting cyclooxygenase and the pharmaceutical compositions
JP5173192B2 (ja) プロトンポンプ阻害薬
JP5735986B2 (ja) 新規抗マラリア剤
JP2005519932A5 (cg-RX-API-DMAC7.html)
JP2007536231A5 (cg-RX-API-DMAC7.html)
EA002113B1 (ru) Производные индазола и их использование в качестве ингибиторов фосфодиэстеразы (фдэ) типа iv и продуцирования фактора некроза опухоли (фно)
SK133297A3 (en) Imidazo[1,2-a]pyridine derivatives, pharmaceutical composition containing same and their use
CA2478232A1 (en) Heterocyclic amide derivatives as cytokine inhibitors
BG64211B1 (bg) Заместени индазолови производни и тяхното използване като инхибитори на фосфодиестераза (pde) тип iv и на произвеждането на туморен некрозен фактор (tnf)
JP2005508960A5 (cg-RX-API-DMAC7.html)
US20040147546A1 (en) Heterocyclic compounds
JP2002538157A (ja) ピラゾロピリジン
JP2005511532A5 (cg-RX-API-DMAC7.html)
JP2007537255A5 (cg-RX-API-DMAC7.html)
JPH08504435A (ja) タキキニン受容体拮抗剤としての４−アミノメチル／チオメチル／スルホニルメチル−４−フェニルピペリジン
JP2005509003A5 (cg-RX-API-DMAC7.html)
JPS62452A (ja) １，８−架橋−４−キノロン−３−カルボン酸類の製造法、それらの中間体類、および薬物としてのそれらの使用
KR20100061849A (ko) ５―원 헤테로시클릭 화합물
JP2006514940A5 (cg-RX-API-DMAC7.html)
WO2000012502A1 (en) Pyrroloquinolines for treatment of obesity
HRP20030141A2 (en) Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors
JP2014513142A (ja) ナフチリジンの調製方法
CA2507184A1 (en) 1, 2, 3- triazole amide derivatives as cytokine inhibitors